Cerexa

Cerexa is a biopharmaceutical company dedicated to developing a range of novel anti-infective therapies for the treatment of serious and life-threatening infections. The company's portfolio includes Ceftaroline Acetate, an injectable cephalosporin used to treat bacterial infections caused by Gram-positive and Gram-negative pathogens.